Deeper Dive: Understanding Amarin Corp ADR (AMRN) Through its Various Ratios

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Amarin Corp ADR (NASDAQ: AMRN) closed at $0.79 in the last session, up 1.27% from day before closing price of $0.78. In other words, the price has increased by $1.27 from its previous closing price. On the day, 1.49 million shares were traded. AMRN stock price reached its highest trading level at $0.8042 during the session, while it also had its lowest trading level at $0.7851.

Ratios:

We take a closer look at AMRN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.93 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

On October 25, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $3 to $1.

Jefferies Upgraded its Hold to Buy on January 06, 2023, whereas the target price for the stock was revised from $1.30 to $3.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 22 ’24 when Holt Patrick bought 14,426 shares for $1.09 per share. The transaction valued at 15,724 led to the insider holds 314,426 shares of the business.

Ketchum Steven B sold 34,131 shares of AMRN for $26,963 on Dec 12 ’23. The Chief Scientific Officer now owns 566,100 shares after completing the transaction at $0.79 per share. On Aug 16 ’23, another insider, Holt Patrick, who serves as the President and CEO of the company, bought 300,000 shares for $1.04 each. As a result, the insider paid 312,315 and bolstered with 300,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRN now has a Market Capitalization of 324545408 and an Enterprise Value of 26480154. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at 0.095 whereas that against EBITDA is -1.155.

Stock Price History:

Over the past 52 weeks, AMRN has reached a high of $1.49, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -0.09%, while the 200-Day Moving Average is calculated to be -11.47%.

Shares Statistics:

According to the various share statistics, AMRN traded on average about 1.47M shares per day over the past 3-months and 1407729 shares per day over the past 10 days. A total of 410.74M shares are outstanding, with a floating share count of 409.14M. Insiders hold about 0.39% of the company’s shares, while institutions hold 22.13% stake in the company. Shares short for AMRN as of 1719532800 were 20428818 with a Short Ratio of 13.88, compared to 1717113600 on 15809853. Therefore, it implies a Short% of Shares Outstanding of 20428818 and a Short% of Float of 5.0300002.

Most Popular